Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001839882-25-009559
Filing Date
2025-02-18
Accepted
2025-02-18 20:56:06
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D  
1 primary_doc.xml SCHEDULE 13D 22141
  Complete submission text file 0001839882-25-009559.txt   23829
Mailing Address 301 COMMERCE STREET SUITE 3300 FORT WORTH TX 76102
Business Address 301 COMMERCE STREET SUITE 3300 FORT WORTH TX 76102 (817) 871-4000
TPG GP A, LLC (Filed by) CIK: 0001903793 (see all company filings)

EIN.: 872054646 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D

Mailing Address 21 HICKORY DRIVE, SUITE 500 WALTHAM MA 02451
Business Address 21 HICKORY DRIVE, SUITE 500 WALTHAM MA 02451 617-819-2020
Sionna Therapeutics, Inc. (Subject) CIK: 0002036042 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D | Act: 34 | File No.: 005-94871 | Film No.: 25636962
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)